Contact
Our Approach
Our Lab
Who We Serve
About
Team
Resources
Our Approach
Our Lab
Who We Serve
About
Team
Resources
Press Release
Back to Resources
08/21/2024 | Press Release | prnewswire
PreciseDx Secures $20.7 Million Series B to Advance AI-Powered Cancer Risk Assessments
Read More
07/23/2024 | Press Release
PreciseDx Announces Publication of Its Cost Impact Study, Payer Impact of PreciseBreast™(PDxBr) to Identify Breast Cancer Recurrence, in the Journal Of Medical Economics
Read More
05/29/2024 | Press Release
COTA, Baptist Health South Florida, and PreciseDx Announce Collaboration on the AI-Enabled Breast Cancer Recurrence Risk Assessment, PreciseBreast™
Read More
05/28/2024 | Press Release
PreciseDx Announces Poster Presentation at The 2024 American Society of Clinical Oncology Annual Meeting
Read More
04/02/2024 | Press Release
UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence
Read More
03/22/2024 | Press Release
PreciseDx Presents New Research on Their AI-Enabled Digital Test at 14th Annual European Breast Conference
Read More
12/22/2023 | Press Release
PreciseDx Collaborates with Baylor Scott & White Health to Validate PreciseBreast™ Assessment for Early-Stage Invasive Breast Cancer Detection
Read More
06/27/2023 | Press Release | PR Newswire
PreciseDx Announces Ted Diehl as Vice President of Commercial Development
Read More
03/08/2023 | Press Release | PR Newswire
PreciseDx to Present on AI-enabled Breast Cancer Grade and Phenotyping Assay at United States and Canadian Academy of Pathology (USCAP) Annual Meeting
Read More
02/21/2023 | Press Release | PR Newswire
PreciseDx Appoints Bradley Gendell as Chief Financial Officer
Read More
1
2
NEXT >
